»» Searching for " FUSILEV "
 Related Search Tags:  SPPI Nasdaq:sppi FUSILEV USFDA Levoleucovorin
Showing Results 1-1 of 1 |  Sort by:     
Page 1 of 1  |  Go to page   
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Spectrum Pharmaceuticals Incorporated - symbol SPPI - reported that the FDA has granted FUSILEV (levoleucovorin) “Orphan Drug” exclusivity for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer. In addition, FUSILEV therapeutic compositions are protected under a US Patent which expires at the end of December 2019 and the company has already filed a patent extension application. Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
(SPPI) Affirms Strong...
Categories: Videos 
Added: 162 days ago
By: karmastock
Runtime: 1m11s
Views: 61
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0485 seconds.